Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a magnetic chair help new moms recover pelvic strength?

NCT ID NCT07528560

Disease control Sponsor: Institut Investigacio Sanitaria Pere Virgili Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a device called Emsella, which uses electromagnetic energy, can strengthen pelvic floor muscles in first-time mothers who had a vaginal delivery. Sixty women will either receive the treatment or follow natural recovery. The goal is to see if the device can restore muscle tone and prevent future problems like incontinence.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
HIFEM (High Intensity Focused Electromagnetic) device (BTL Emsella)
What this could lead to
If it works, this could offer a non-invasive way to help new mothers restore pelvic floor strength after childbirth.
What could go wrong
This is a small, non-randomized early study with only 60 participants. It may not show a clear benefit over natural recovery, and results may not apply to all women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Primiparous women * Vaginal delivery. * Single-fetus pregnancy / Singleton pregnancy. * Full-term pregnancy (\> 37 weeks of gestation). * Asymptomatic: No symptoms associated with pelvic floor muscle weakening, such as any type of incontinence or presence of prolapse. * Post-quarantine period: Between 6 and 12 weeks postpartum Exclusion Criteria: * Implanted devices: Such as pacemakers, defibrillators, or neurostimulators. * Electronic implants. * Drug delivery pumps (e.g., insulin pumps or medication infusion pumps). * Metallic implants. * Intrauterine devices (IUDs) containing any type of metal. * Application over the growth plate area. * Severe or life-threatening disorders. * Pulmonary insufficiency. * Cardiac disorders / Heart conditions. * Decompensated hemorrhagic conditions. * Decompensated blood coagulation disorders. * Malignant tumors / Malignancy. * Fever. * Epilepsy. * Menstruation * Pregnant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pelvic floor muscle dysfunction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Sprains and Strains

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pelvic floor muscle dysfunction

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centro Procrear

    RECRUITING

    Tarragona, TARRAGONA, 43002, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.